[HTML][HTML] Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
D Tiwari, AR Martineau - Seminars in Immunology, 2023 - Elsevier
Abstract Treatment of tuberculosis (TB) involves the administration of anti-mycobacterial
drugs for several months. The emergence of drug-resistant strains of Mycobacterium …
drugs for several months. The emergence of drug-resistant strains of Mycobacterium …
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities
BACKGROUND: Pulmonary TB (PTB) and chronic pulmonary aspergillosis (CPA) are both
progressive and debilitating parenchymal lung diseases with overlapping risk factors …
progressive and debilitating parenchymal lung diseases with overlapping risk factors …
Tuberculosis prevalence: beyond the tip of the iceberg
The global burden of tuberculosis disease remains stubbornly high. Population surveys
estimate that 14 million individuals have prevalent disease, reflecting around 10 million …
estimate that 14 million individuals have prevalent disease, reflecting around 10 million …
[HTML][HTML] Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
M Muñoz-Torrico, A Rendon, R Centis… - Jornal Brasileiro de …, 2016 - SciELO Brasil
The role of tuberculosis as a public health care priority and the availability of diagnostic tools
to evaluate functional status (spirometry, plethysmography, and DLCO determination) …
to evaluate functional status (spirometry, plethysmography, and DLCO determination) …
Strategies to increase childhood tuberculosis case detection at the primary health care level: Lessons from an active case finding study in Zambia
M Kagujje, S Nyangu, MM Maimbolwa, B Shuma… - PLoS …, 2023 - journals.plos.org
Introduction In high TB burden settings, it is estimated that 10–20% of total notifications
should be children, however, currently only 6–8% of the total TB notifications in Zambia are …
should be children, however, currently only 6–8% of the total TB notifications in Zambia are …
[HTML][HTML] Imbalance of NET and alpha-1-antitrypsin in tuberculosis patients is related with hyper inflammation and severe lung tissue damage
MGM de Melo, EDD Mesquita, MM Oliveira… - Frontiers in …, 2019 - frontiersin.org
Background: Pulmonary tuberculosis (PTB) can lead to lung tissue damage (LTD) and
compromise the pulmonary capacity of TB patients that evolve to severe PTB. The molecular …
compromise the pulmonary capacity of TB patients that evolve to severe PTB. The molecular …
Pulmonary impairment in tuberculosis survivors: the Korean National health and nutrition examination survey 2008-2012
JW Jung, JC Choi, JW Shin, JY Kim, BW Choi, IW Park - PloS one, 2015 - journals.plos.org
Objectives Pulmonary tuberculosis (TB) can affect lung function, but studies regarding long-
term follow-up in patients with no sequelae on chest X-ray (CXR) have not been performed …
term follow-up in patients with no sequelae on chest X-ray (CXR) have not been performed …
Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis
Y Ma, R Li, J Shen, L He, Y Li, N Zhang, Q Wu… - BMC infectious …, 2019 - Springer
Background The goal of this study was to further investigate the clinical effectiveness of the T-
SPOT. TB test in diagnosing tuberculosis (TB), including the effects of T-SPOT. TB test on …
SPOT. TB test in diagnosing tuberculosis (TB), including the effects of T-SPOT. TB test on …
Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis
TT Jiang, LY Shi, LL Wei, X Li, S Yang, C Wang… - PloS one, 2017 - journals.plos.org
The aim of this study was to discover novel biomarkers for pulmonary tuberculosis (TB).
Differentially expressed proteins in the serum of patients with TB were screened and …
Differentially expressed proteins in the serum of patients with TB were screened and …
The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control
Tuberculosis (TB) is one of the top ten causes of death worldwide. In 2016, there were
490,000 cases of multi-drug resistant TB globally. Over 2 billion people have asymptomatic …
490,000 cases of multi-drug resistant TB globally. Over 2 billion people have asymptomatic …